DPCO list December 2022

DPCO list of 12 items December 2022

NPPA fixed the price of 12 formulations in its 105th meeting held on 15.12.2022. Read the consolidated dpco list December 2022 below.

According to the notification of NPPA order No. 5939(E) was published on 19. December 2022 on its official website. In this DPCO list, many very common products included that have a good share in the market sale like Atorvastatin Tablets, Cefuroxime dry syrup, Lamivudine Tablets, Itraconazole syrup, Valganciclovir tablets, Montelukast tablet, Daclatasvir tablet, and Dolutegravir tablets.

This is the last update of DPCO orders for included formulations of the year 2022. There is no chance for any revision of prices for these items in the current year.

The version of the order are given here below as per the original orders are on the website as:-

ORDER

S.O. 5939(E):– In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17, and 18 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated 30th May 2013 and S.O. 5249(E) dated 11th November 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the prices as specified in column (5) of the table herein below as ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2) of the said Table with the dosage form & strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof:

 

SN. Name of the Scheduled FormulationDosage form and strength 

 

Unit

Ceiling Price (Rs.)
(1) (2) (3) (4) (5)
1.AtorvastatinTablet 80mg1 Tablet36.19
2.CefuroximeOral liquid 125mg/5mL(p)1 ML4.71
3.LamivudineTablet 100mg1 Tablet9.28
4.LamivudineTablet 150mg1 Tablet9.69
5.ItraconazoleOral liquid 10mg/mL1 ML4.41
6.ValganciclovirTablet 450 mg1 Tablet357.39
7.LenalidomideCapsule 5mg1 Capsule59.98
8.MontelukastTablet 4 mg1 Tablet8.95
9.

Montelukast

Tablet 5 mg (including chewable Tablet s)

1 Tablet

10.45

10.MontelukastTablet 10 mg1 Tablet14.66
11.DaclatasvirTablet 60mg1 Tablet178.34
12.DolutegravirTablet 50mg1 Tablet100.59
table

Important Notes for this order are listed below that conditions will be applicable to the order.

  • All manufacturers of scheduled formulation, selling the branded or generic or both versions of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any.
  • All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013.
  • The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above-said table.
  • The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
  • As per para 24(4) of DPCO 2013, every retailer and dealer shall display the price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
  • Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
  • The manufacturers of above said scheduled formulations shall furnish quarterly returns to the NPPA, in respect of production/import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and/or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
  • The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
  • Consequent to the issue of the ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

FREQUENTLY ASKED QUESTIONS

What is the DPCO price of Atorvastatin Tablet 80 mg?

The latest DPCO price of the Atorvastatin Tablet 80 mg is Rs. 36.19 as per order no. S.O. 5939(E) of 19.12.2022.

What is the NPPA price of Cefuroxime dry syrup 125mg/ml?

The latest DPCO price of the Cefuroxime dry syrup 125mg/ml is Rs. 4.71 per ml as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of Lamivudine Tablet 100 mg?

The latest DPCO price of the Lamivudine Tablet 100 mg is Rs. 9.28 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of Lamivudine Tablet 150 mg?

The latest DPCO price of the Lamivudine Tablet 150 mg is Rs. 9.69 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of Itraconazole syrup?

The latest DPCO price of the itraconazole Oral liquid 10mg/mL is Rs. 4.41 per ml as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of Valganciclovir Tablet 450 mg?

The latest DPCO price of the Valganciclovir Tablet 450 mg is Rs. 357.39 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of Lenalidomide capsule 5 mg?

The latest DPCO price of the Lenalidomide capsule 5 mg is Rs. 59.98 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of the Montelukast tablet 4 mg?

The latest DPCO price of the Montelukast tablet 4 mg is Rs. 8.95 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of the Montelukast tablet 5 mg?

The latest DPCO price of the Montelukast tablet 5 mg (including chewable Tablet s) is Rs.10.45 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of the Montelukast tablet 10 mg?

The latest DPCO price of the Montelukast tablet 10 mg is Rs. 14.66 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of the Daclatasvir tablet 60 mg?

The latest DPCO price of the Daclatasvir tablet 60 mg is Rs. 178.34 as per order no. S.O. 5939(E) of 19.12.2022.

What is the DPCO price of the Dolutegravir tablet 50 mg?

The latest DPCO price of the Dolutegravir tablet 50 mg is Rs. 100.59 as per order no. S.O. 5939(E) of 19.12.2022.

Related Posts:

Darshan Singh

The author has 20 years of experience in the Pharmaceutical Manufacturing Companies. Have exposure to all audit documents for WHO-GMP, PIC/S, USFDA, Export documents, US-FDA documents, Validation of Pharma machinery, and Quality Control Instruments. Expert in Pharma Plant Setup and sale and acquisition of running pharma company.

https://www.laafon.com

Leave a Reply

Your email address will not be published. Required fields are marked *

× How can I help you?